Cynthia M. Carver DeKlotz, MD, specializes in Adult and Pediatric Dermatology at MedStar Washington Hospital Center (MWHC) and MedStar Georgetown University Hospital. In addition to her clinical responsibilities, she is an assistant professor of Clinical Medicine and Pediatrics; director of the Orthopedics, Rheumatology, and Dermatology module; and co-director of the Immunology, Rheumatology, and Dermatology module at Georgetown University School of Medicine.
Dr. DeKlotz is board certified in dermatology, pediatric dermatology, and internal medicine. In her clinical practice, she specializes in genetic skin disease as well as general medical pediatric dermatology. She is skilled in laser treatment of birthmarks, laser scar revisions, acne surgery, Botox injection, chemical peels, and dermal fillers.
As the director of the Orthopedics, Rheumatology, and Dermatology module and co-director of the Immunology, Rheumatology, and Dermatology module at Georgetown University School of Medicine, Dr. DeKlotz spends time teaching and mentoring medical students. To further contribute to advances in evidence-based practice, she reviews manuscripts for JAMA Dermatology, and she has participated as a principal investigator and subinvestigator on studies of pharmaceutical treatments for dermatology patients. Her research has been published in the Journal of the American Academy of Dermatology, Archives of Disease in Childhood, Pediatric Dermatology, and other peer-reviewed publications.
Dr. DeKlotz is an experienced presenter who is frequently invited to speak at local and national dermatology meetings and conferences, in addition to regularly lecturing medical students and residents. Topics she has presented have included rare genetic conditions, such as tuberous sclerosis and incontinentia pigmenti, as well as common childhood infectious diseases and reactive rashes and management of acne.
She graduated summa cum laude from Georgetown University School of Medicine with a degree in medicine, where she was a member of Alpha Omega Alpha. She completed an internship and residency in internal medicine/dermatology at Georgetown University Hospital/MedStar Washington Hospital Center. She then completed a fellowship in pediatric dermatology at Rady Children's Hospital/University of California, San Diego. Dr. DeKlotz also has a master’s degree in advanced mathematics from the University of Cambridge, Cambridge, England.
Dr. DeKlotz’s research interests include the following:
- Genetic skin diseases (genodermatoses)
- Laser treatment (particularly fractional CO2 laser)
- Safety and efficacy of topical ointments
Efficacy and Safety of Dupilumab Monotherapy in Adolescents with Moderate-to-Severe Atopic Dermatitis
Dr. DeKlotz is a site principal investigator on this study of a treatment for moderate-to-severe eczema in adolescents. This randomized, double-blind, placebo-controlled study is sponsored by Regeneron Pharmaceuticals.
Evaluation of the Long-Term Safety of Zorblisa (SD-101-6.0) in Patients with Epidermolysis Bullosa (ESSENCE Study)
Dr. DeKlotz is a site principal investigator on this phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of SD-101-6.0 cream in the treatment of patients with epidermolysis bullosa. This study is sponsored by Scioderm/Amicus Therapeutics.
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Kerydin (tavaborole) Topical Solution, 5%, in the Treatment of Onychomycosis of the Toenail in Children
Dr. DeKlotz served as site principal investigator on this study of a treatment for toenail fungus.
Systemic Retinoids and Epidermal Growth Factor Inhibitors: Effects on Cancer Cell Lines
Dr. DeKlotz served as a principal investigator on this MWHC-funded study.
- Research Areas
- Other Medical